Stocks · Healthcare · Medical - Instruments & Supplies

OraSure Technologies, Inc. OSUR

$3.97 +2.32% Close, Oct 2, 2026 · NASDAQ · Market cap $273.0M

Next earnings report: Nov 4, 2026

Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.

Three things to know

  1. Operating margin narrowed to -44.7% from -38.1% a year earlier.
  2. Revenue over the last four quarters was $112.4M, down 18.9% from a year earlier, accelerating from -30.1% a quarter earlier.
  3. The diluted share count fell 5.9% in a year, mainly through buybacks.

PromtFinance scores

Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.

Growth23Very weak

How fast revenue, earnings and cash flow are growing.

  • Revenue growth (TTM, YoY)Bottom 16%
  • Revenue growth, 3-year CAGRBottom 4%
  • Revenue growth accelerationTop 13%
Quality22Very weak

Returns on capital, margins, earnings quality and balance-sheet strength.

  • Return on invested capitalTop 46%
  • Gross marginBottom 26%
  • Operating marginBottom 36%
  • Accruals (lower is better)Bottom 22%
Value42Weak

How cheap the shares are relative to earnings, cash flow and their own history.

  • Earnings yieldBottom 37%
  • Free-cash-flow yieldBottom 26%
  • EBITDA / enterprise valueBottom 19%
  • Sales / enterprise valueTop 11%
Momentum74Positive

Strength and persistence of the price trend, including versus the S&P 500.

  • 12-month return excluding last monthBottom 45%
  • 6-month returnTop 33%
  • 1-year return vs S&P 500Top 40%
  • Distance from 52-week highTop 21%
  • Trend checklist (0–4)Top 7%
Revisions7Very weak

Earnings surprises and analyst sentiment (estimate-revision history is being collected).

  • Average EPS surprise, last 4 quartersTop 49%
  • Consecutive EPS beatsBottom 49%
  • Share of analysts rating BuyBottom 4%
  • Upside to consensus price targetBottom 11%
Stability71Positive

Low volatility, shallow drawdowns, low market sensitivity and modest leverage.

  • Volatility, 60 days (lower is better)Top 25%
  • Maximum drawdown, 3 yearsBottom 42%
  • Beta vs S&P 500 (lower is better)Top 30%

What changed

Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).

MeasureBeforeNow
Revenue growth (YoY)-30.1%-18.9%↑
Gross margin40.7%41.4%↑
Operating margin-38.1%-44.7%↓
FCF margin-14.5%-42.8%↓

Fundamental momentum

MeasureNow (TTM)Year / quarter beforeSector rank
Revenue growth (TTM, YoY)-18.9%-30.1%↑Bottom 16%
Gross margin41.4%40.7%↑Bottom 26%
Operating margin-44.7%-38.1%↓Bottom 36%
Net margin-43.7%-36.8%↓—
Free-cash-flow margin-42.8%-14.5%↓—
Return on invested capital-14.9%—Top 46%
Revenue growth, 3-year CAGR-33.3%—Bottom 4%

Quality of earnings and balance sheet

Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
-1.7%
Stock-based compensation / revenueA cost to shareholders through dilution.
9.4%
Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
+17.7 pp
Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
Net cash

Shareholder returns

Dividend yield (dividends paid, TTM)
0.00%
Net buyback yield (TTM)
6.24%
Shareholder yield
6.24%
Share count change, 1 year
-5.9%
Share count change, 3-year CAGR
-1.5%

Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.

Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).

Earnings and expectations

Earnings momentum

Consecutive EPS beats
1
Beats in the last 8 reports
1 of 8
Average EPS surprise, last 4
+4.2%
Average 2-day reaction, last 8
+0.2%
Positive 20 days after report
4 of 8

Analysts

Consensus price target
$4.00
Target vs current price
+0.8%
Analysts with a rating
13
Share rating Buy or Strong Buy
31%
Consensus rating
Hold

How the stock reacted to recent reports

Report dateEPS surprise2 days5 days20 days60 days
Aug 5, 2026+133.3%-0.5%-7.0%-15.3%—
May 6, 2026-39.1%+0.0%-1.0%+31.7%+35.0%
Feb 25, 2026-58.8%-0.7%+5.7%+8.5%+8.9%
Nov 5, 2025-18.8%+0.0%-4.3%-0.8%+13.6%
Aug 5, 2025-36.8%+0.0%-10.6%+7.7%-8.0%
May 7, 2025-20.0%-0.4%-5.4%+3.6%+7.5%
Feb 25, 2025-180.0%+0.3%-10.5%-8.3%-29.8%
Nov 6, 2024-50.0%+2.6%-3.5%-9.8%-6.5%

Returns from the close before each report. Past reactions do not determine future ones.

Earnings history

Report dateEPSEstimateSurpriseRevenue
Aug 5, 2026$0.09-$0.27+133.3%$30.6M
May 6, 2026-$0.32-$0.23-39.1%$27.9M
Feb 25, 2026-$0.27-$0.17-58.8%$26.7M
Nov 5, 2025-$0.19-$0.16-18.8%$27.1M
Aug 5, 2025-$0.26-$0.19-36.8%$31.2M
May 7, 2025-$0.18-$0.15-20.0%$29.9M
Feb 25, 2025-$0.14-$0.05-180.0%$37.4M
Nov 6, 2024-$0.06-$0.04-50.0%$39.9M

Valuation in context

MultipleNow5-year median5-year percentileSector rank (cheapness)
EV / Sales1.11×——Top 11%
Free-cash-flow yield-17.61%——Bottom 26%
Earnings yield-17.38%——Bottom 37%

P/E over the past five years

Range 8.9× – 168.5× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.

Technical state

Trend checklist

  • ✓ Price above 20-day average
  • ✓ Price above 50-day average
  • ✓ Price above 200-day average
  • ✓ 50-day average above 200-day
  • ✓ MACD histogram positive

Trend quality

Days above the 50-day average
9
Days above the 200-day average
15
50-day average slope (20 days)
-5.5%
200-day average slope (20 days)
+3.8%
Distance from 50-day average
+5.1%
Distance from 200-day average
+17.7%
RSI (14)
60.7
Relative volume
0.66×

Risk and drawdowns

Volatility, 60 days (annualized)
42.2%
Volatility vs own 5-year history
19th percentile · Low for this stock
Beta vs S&P 500 (2 years, weekly)
0.78
Correlation with S&P 500
0.27
Current drawdown from 1-year high
-11.8%
Maximum drawdown, 3 years
-74.7%

Largest declines in the past six years

From peakTo lowDeclineLengthRecovery
Oct 19, 2020Nov 20, 2025-86.8%1279 daysNot yet recovered
Oct 9, 2020Oct 16, 2020-10.2%5 days1 days (Oct 19, 2020)

Declines of 10% or more from a closing high, measured on daily closes.

Financial statements

Market cap
$273.0M
EPS, diluted (TTM)
-$0.69
Revenue (TTM)
$112.4M
52-week range
$2.08 – $4.58
FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$233.7M$387.5M$405.5M$185.8M$115.0M
Gross profit$117.6M$148.4M$179.4M$76.2M$48.2M
Operating income-$11.6M-$5.2M$54.1M-$20.6M-$68.1M
Net income-$23.0M-$17.1M$53.7M-$19.5M-$68.7M
EPS (diluted)-$0.32-$0.25$0.72-$0.26-$0.94
Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Revenue$39.9M$37.4M$29.9M$31.2M$27.1M$26.8M$27.9M$30.6M
Net income-$4.5M-$10.8M-$16.0M-$19.7M-$13.7M-$19.3M-$22.4M$6.2M
EPS (diluted)-$0.06-$0.14-$0.21-$0.26-$0.19-$0.27-$0.32$0.09
FY 2021FY 2022FY 2023FY 2024FY 2025
Operating cash flow-$35.4M-$47.2M$141.6M$27.4M-$49,023
Capital expenditure-$48.1M-$63.9M-$10.3M-$3.8M-$4,197
Free cash flow-$83.5M-$111.1M$131.3M$23.6M-$53,220
Dividends paid$0$0$0$0$0
Net share buybacks-$2.1M-$2.3M-$1.9M-$3.5M-$15.0M

Cash outflows are shown as negative numbers.

Cash and short-term investments
$160.6M
Total assets
$360.6M
Total liabilities
$42.8M
Total debt
$12.1M
Net debt
-$148.5M
Shareholders’ equity
$317.8M

As of Jun 30, 2026 (filed Aug 7, 2026).

Dividends

Ex-dateAmountPaid
Jan 8, 1998$1.60—

Short interest

Shares sold short
3,172,198
Days to cover
5.98
Change vs previous report
+1.4%

FINRA short interest, settlement date Sep 15, 2026.

Stock splits

Apr 8, 1987
3-for-1